Angiotensin Ii
规格
4474-91-3CAS 号
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-meIUPAC 名称
C50H71N13O12化学式
1046.2 g/mol分子量
ANGIOTENSIN II; 4474-91-3; Human angiotensin II; Angiotensin II (human); Ang II; 5-L-Isoleucineangiotensin II; 5-Isoleucine-angiotensin II; Angiotensin II (mouse); Asp-Arg-Val-Tyr-Ile-His-Pro-Phe; 1-8-Angiotensin I; Isoleucine5-angiotensin II; angiotensine II; ANG-(1-8)Octapeptide; Angiotensina II; Angiotensin II (human type); Delivert; LJPC-501; Angiotensinum II; M089EFU921; 5 L Isoleucine Angiotensin II; Valyl(5)-Angiotensin II; Isoleucine(5)-Angiotensin; Isoleucyl(5)-Angiotensin II; Angiotensin II, Valine(5)-; 5-L-Isoleucine Angiotensin II; Angiotensin-(1-8) Octapeptide; DTXSID4036778; Angiotensin II, 5-L-Isoleucine; Angiotensin II, Isoleucine(5)-; (3S)-3-amino-3-(((1S)-1-(((1S)-1-(((1S)-1-(((1S,2S)-1-(((2S)-1-((2S)-2-(((1S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)carbamoyl)-2-methylbutyl)carbamoyl)-2-(4-hydroxyphenyl)ethyl)carbamoyl)-2-methylpropyl)carbamoyl)-4-((diaminomethylidene)amino)butyl)carbamoyl)propanoic acid; (3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl]carbamoyl}propanoic acid; RefChem:56778; Therapeutic Angiotensin II; CHEBI:48432; C01CX09; (3S)-3-amino-4-(((2S)-1-(((2S)-1-(((2S)-1-(((2S,3S)-1-(((2S)-1-((2S)-2-(((1S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-(diaminomethylideneamino)-1-oxopentan-2-yl)amino)-4-oxobutanoic acid; (3S)-3-amino-4-(((2S)-5-(diaminomethylideneamino)-1-(((2S)-1-(((2S)-1-(((2S,3S)-1-(((2S)-1-((2S)-2-(((2S)-1-hydroxy-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrrolidin-1-yl)-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxopentan-2-yl)amino)-4-oxobutanoic acid; Angiotensin II human; Hypertensin; Giapreza; Angiotensin II, human; Ile(5)-angiotensin II; DRVYIHPF; MFCD00161484; isoleucine(5)-angiotensin II; CHEBI:2719; CHEMBL408403; Angiotensin II acetate salt; 1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide; L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine; (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid; (2S,5S,8S,11S,14S,17S)-2-((1H-Imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid; C50H71N13O12; N-(1-(N-(N-(N-(N-(N(2)-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine; Ile5-angiotensin II; Angiotensin II, ile(5)-; Angiotensin ii [INN:JAN]; UNII-M089EFU921; Angiotensin 2; ty-10721; Angiotensin II, 5-L-isoleucine-; Delivert (TN); Angiotensin II heavy; Angiotensin II (9CI); Angiotensin II (USAN); ANGIOTENSIN II,HUMAN; SCHEMBL1189; (3S)-3-AMINO-3-{[(1S)-4-CARBAMIMIDAMIDO-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-CARBOXY-2-PHENYLETHYL]CARBAMOYL}PYRROLIDIN-1-YL]-3-(1H-IMIDAZOL-4-YL)-1-OXOPROPAN-2-YL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}BUTYL]CARBAMOYL}PROPANOIC ACID; Angiotensin II (acetate);Ang II (acetate);DRVYIHPF (acetate); GTPL2504; orb1225028; SCHEMBL1650427; SCHEMBL9013957; SCHEMBL29361861; DTXSID30196288; CHEBI:131170; GLXC-21208; Angiotensin II (human type) (JAN); BDBM50228195; BDBM50236697; EBC-27517; HB3488; AKOS016010178; DB11842; FA73187; NCGC00167130-01; DA-70862; HY-13948; L-Phenylalanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-; SY113109; NS00074073; Asp1-Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8; C02135; C75211; D02014; DRVY-I*-HPF [I*= I(13C6,15N)]; EN300-19742056; Q412999; ANG-(1-8)Octapeptide, Hypertensin, 4474-91-3, Giapreza; Conalbumin (328-332), 1226776-54-0, RVPSL peptide; ProteoMass(TM) Angiotensin II MALDI-MS Standard, vial of 10 nmol; (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-4-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid; (3S)-3-amino-4-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S,2S)-1-[[(1S)-2-[(2S)-2-[[(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]pyrrolidin-1-yl]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]carbamoyl]-2-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]carbamoyl]-4-guanidino-butyl]amino]-4-oxo-butanoic acid; Alanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-3-phenyl-, L-; L-phenylalanine, L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-同义词
